Trials / Completed
CompletedNCT03852810
Satisfaction With XEN Gel Stent Versus Trabeculectomy for the Treatment of Glaucoma
Patient Reported Outcomes for XEN Gel Stent Versus Trabeculectomy for the Treatment of Glaucoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 28 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, observational, non-interventional study of patients scheduled to receive surgical intervention either via XEN or trabeculectomy for open-angle glaucoma. The decision to treat patients with a particular surgical procedure will not be influenced by the study as the treatment decision will continue to be made by the patient and the clinician. There will be no study mandated visits or treatments.
Conditions
Timeline
- Start date
- 2019-02-25
- Primary completion
- 2020-12-09
- Completion
- 2020-12-09
- First posted
- 2019-02-25
- Last updated
- 2021-10-20
Locations
10 sites across 3 countries: Canada, Germany, United Kingdom
Source: ClinicalTrials.gov record NCT03852810. Inclusion in this directory is not an endorsement.